LRRK2 and Parkinson disease: Our studies on neurons in vitro identified two secretory pathways that are upregulated in both primary mouse cortical neurons and human iPSC-derived glutamatergic neurons expressing PD-associated mutations that induce hyperactive LRRK2 activity.